| Financial Year |
March 31 2023 |
| Monetary Funds |
41,591,816.08 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
291,486,632.92 |
| Advances to Suppliers |
65,084,481.17 |
| Other Receivables |
405,221,790.28 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
11,700,337.35 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
16,917,684.75 |
| Total Current Assets |
973,378,769.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
406,840,579.24 |
| Investment Properties |
285,982,917.64 |
| Fixed Assetes |
573,397,028.21 |
| Under-construction Projects |
15,540,573.74 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
285,919,699.72 |
| R&D expenses |
-- |
| Goodwill |
250,303,142.92 |
| Long-Term Deferred and Prepaid Expenses |
176,497,930.63 |
| Deferred Income Tax Assets |
50,722,457.82 |
| Other Non-Current Assets |
612,656,201.16 |
| Sub-Total of Non-Current Assets |
3,039,086,727.22 |
| Total Assets |
4,012,465,496.22 |
| Short-Term Loans |
1,270,615,179.80 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
388,166,070.10 |
| Accounts Received In Advance |
27,086,658.57 |
| Employee Compensation Payable |
24,726,383.70 |
| Taxes Payable |
243,883,902.12 |
| Interest Payable |
492,464,986.92 |
| Dividend Payable |
2,077,812.91 |
| Other payables |
1,388,519,405.18 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
649,722,928.85 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
4,008,605,437.31 |
| Long-term Loans |
322,713,008.13 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
7,107,637.72 |
| Deferred Income Tax Liabilities |
41,849,204.68 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
839,374,798.76 |
| Total Liabilities |
4,847,980,236.07 |
| Paid-In Capital(Or Share Stock) |
877,697,557.00 |
| Capital Surplus |
373,120,895.51 |
| Surplus Reserve |
98,602,786.68 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-2,266,615,869.21 |
| Minority Stockholder's Interest |
22,411,149.90 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-857,925,889.75 |
| Owner's Equity（Stockholder's Equity） |
-835,514,739.85 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,012,465,496.22 |
